Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68

BACKGROUND: Oncolytic viral therapy represents an alternative therapeutic strategy for the treatment of cancer. We previously described GLV-1h68, a modified Vaccinia Virus with exclusive tropism for tumor cells, and we observed a cell line-specific relationship between the ability of GLV-1h68 to rep...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ascierto, Maria Libera, Worschech, Andrea, Yu, Zhiya, Adams, Sharon, Reinboth, Jennifer, Chen, Nanhai G, Pos, Zoltan, Roychoudhuri, Rahul, Di Pasquale, Giovanni, Bedognetti, Davide, Uccellini, Lorenzo, Rossano, Fabio, Ascierto, Paolo A, Stroncek, David F, Restifo, Nicholas P, Wang, Ena, Szalay, Aladar A, Marincola, Francesco M
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2011
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3213037/
https://ncbi.nlm.nih.gov/pubmed/22011439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-451
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires